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Objectives: Hypertension is a major risk factor for white matter hyperintensities (WMH),
lacunes, cerebral microbleeds, and perivascular spaces, which are MRI markers of
cerebral small vessel disease (SVD). Studies have shown associations between these
individual MRI markers and cognitive functioning and decline. Recently, a “total SVD
score” was proposed in which the different MRI markers were combined into one
measure of SVD, to capture total SVD-related brain damage. We investigated if this SVD
score was associated with cognitive decline over 4 years in patients with hypertension.
Methods: In this longitudinal cohort study, 130 hypertensive patients (91 patients
with uncomplicated hypertension and 39 hypertensive patients with a lacunar stroke)
were included. They underwent a neuropsychological assessment at baseline and after
4 years. The presence of WMH, lacunes, cerebral microbleeds, and perivascular spaces
were rated on baseline MRI. Presence of each individual marker was added to calculate
the total SVD score (range 0–4) in each patient.
Results: Uncorrected linear regression analyses showed associations between SVD
score and decline in overall cognition (p = 0.017), executive functioning (p < 0.001)
and information processing speed (p = 0.037), but not with memory (p = 0.911). The
association between SVD score and decline in overall cognition and executive function
remained significant after adjustment for age, sex, education, anxiety and depression
score, potential vascular risk factors, patient group, and baseline cognitive performance.
Conclusion: Our study shows that a total SVD score can predict cognitive decline,
specifically in executive function, over 4 years in hypertensive patients. This emphasizes
the importance of considering total brain damage due to SVD.
Keywords: Small vessel disease, cognitive decline, executive functioning, hypertension, white matter
hyperintensities, cerebral microbleeds, lacunes, perivascular spaces
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INTRODUCTION
Hypertension is a major risk factor for brain damage such
as white matter hyperintensities (WMH), lacunes, cerebral
microbleeds, and perivascular spaces (Veglio et al., 2009). These
MRI markers of brain damage result from small vessel disease
(SVD). Several cross-sectional studies have investigated the
implications of these MRI markers on cognition and showed
significant associations with lower cognitive functioning or
cognitive impairment (de Groot et al., 2000; van der Flier et al.,
2005; Pantoni et al., 2007; Carey et al., 2008). Also in longitudinal
research, associations between decline in cognitive functioning
and WMH and lacunes have been found (Vermeer et al., 2003;
Prins et al., 2005; Jokinen et al., 2011; Pavlovic et al., 2014).
Studies in cerebral microbleeds and perivascular spaces are more
sparse, but a few studies have reported that these might also be
related to cognitive decline or a higher risk of incident dementia
(Zhu et al., 2010; Gregoire et al., 2012).
These previous studies mostly focused on the different MRI
markers of SVD separately. There are some studies investigating
the combined effect of WMH and lacunes on cognitive function
or decline (Baune et al., 2009; Jokinen et al., 2011), but no
study combined all MRI markers. Recently, a “total SVD score”
was proposed to combine all individual MRI markers into one
measure of SVD, which aims to capture total brain damage
from SVD (Staals et al., 2014). This total SVD score was found
to be associated with higher blood pressure levels (Klarenbeek
et al., 2013b), hypertension, age, and other risk factors for SVD
(Staals et al., 2014). Two recent cross-sectional studies have
shown that this total SVD score was related to lower cognitive
performance (Huijts et al., 2013; Staals et al., 2015). However, the
SVD score, combining all four markers, has never been applied in
longitudinal research, studying cognitive decline.
The aim of the present study was to investigate if the SVD
score was associated with cognitive decline over 4 years in
hypertensive patients. To compose a patient cohort with a broad
spectrum of severity of cerebral SVD, we included patients with
uncomplicated hypertension as well as hypertensive patients with
a prior clinical lacunar stroke. In addition, we examined if each
of the MRI markers in this SVD score individually contributed to
cognitive decline, in which it was expected that WMH make the
largest contribution to cognitive decline
MATERIALS AND METHODS
Study Population
We included patients with hypertension, who were selected from
two larger studies: the hypertension and brain damage study
(HYBRiD) (Henskens et al., 2008) and the cognitive function in
small vessel stroke study (Huijts et al., 2013).
In HYBRiD, essential hypertensive patients were recruited
from the hypertension outpatient clinic of the Department of
Internal Medicine of Maastricht University Medical Centre, the
Netherlands. Hypertension was defined as an off-medication,
clinically measured conventional blood pressure ≥140 mm Hg
systolic and/or ≥90 mm Hg diastolic. Exclusion criteria were
a history of symptomatic cardio- or cerebrovascular disease or
contraindications for MRI. Details about the HYBRiD study have
been described before (Henskens et al., 2008). A total of 218
patients were included in the HYBRiD study and they were asked
to participate in the present study.
In the cognitive function in small vessel stroke study,
first-ever lacunar stroke patients were recruited from the
Neurology Department of the Maastricht University Medical
Centre between February 2009 and July 2012. Lacunar stroke
was defined as an acute stroke syndrome with a small (<20mm)
ischemic lesion on acute brain MR in the brain stem, basal ganglia
or internal capsule, compatible with the occlusion of a single
perforating small artery. If no such lesion was visible, we used
established clinical criteria for lacunar stroke (De Jong et al.,
2002). Patients with severe comorbidity, either neurological or
psychiatric, were excluded. Furthermore, patients with possible
other causes for the lacunar stroke than cerebral SVD (cardiac
embolic source, cerebral large vessel disease, or carotid stenosis),
were also excluded (Huijts et al., 2013). A total of 77 patients
were included in the small vessel stroke study, and those who had
hypertension (defined as the use of antihypertensive medication
or a history of hypertension) were selected for the present
analysis.
All patients underwent a brain MRI scan and a
neuropsychological assessment. For hypertensive lacunar stroke
patients, the neuropsychological assessment was performed
3 months after stroke to exclude acute phase effects. The
neuropsychological assessment was repeated 4 years later.
Registration of educational level was based on the Dutch
classification system “Verhage” [in which levels 1, 2, 3, and 4
are considered as low education, level 5 is considered as middle
education and levels 6 and 7 are considered as high education
(Verhage, 1964)]. Information about vascular risk factors [body
mass index (BMI), smoking, and the presence of diabetes
mellitus or hypercholesterolemia] was obtained based on patient
self-report.
The Medical Ethics Committee of the Maastricht University
Medical Centre approved this study and all participants gave
written informed consent.
MRI Data
All HYBRiD patients were scanned on a 1.5T MRI scanner,
while the lacunar stroke patients were scanned using a 1.5T
or a 3T scanner (both scanners: Philips Medical Systems, Best,
The Netherlands). For lacunar stroke patients, the median time
between stroke and MRI was 6 days (IQR = 3.5–32.5). On brain
MRI scans (standard axial T2-weighted, FLAIR and T2∗ gradient
echo sequences, details are described in Supplementary Data
Sheet) two experienced vascular neurologists individually rated
the markers of SVD. The inter-rater agreement statistics have
been previously reported (Huijts et al., 2013). An ordinal scale
representing the total burden of SVD was created. Definitions
and rating method have been described in detail before (Staals
et al., 2014). In short, the presence of each of the four MRI
markers for SVD (WMH, lacunes, cerebral microbleeds and
perivascular spaces) was counted to retrieve a total SVD score
(ranging 0–4). WMH were assessed according to the Fazekas
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scale (Fazekas et al., 1987). Presence of WMH was defined as
periventricular WMH Fazekas score 3 (irregular hyperintensities
extending into the deep white matter) and/or deep WMH
Fazekas score 2 or 3 (confluent hyperintensities). Lacunes and
cerebral microbleeds were assessed according to the international
consensus definition (Wardlaw et al., 2013) and for both lacunes
and cerebral microbleeds, one point was awarded in the total
SVD score if at least one lacune or cerebral microbleed was
present. The recent symptomatic small subcortical infarct in the
lacunar stroke patients was not counted as a lacune, because the
SVD score intends to rate background SVD burden. Perivascular
spaces were rated as mild, moderate or extensive at the level of
the basal ganglia, since perivascular spaces in the basal ganglia are
specifically related to SVD (Doubal et al., 2010; Potter et al., 2015).
One point was awarded for moderate or extensive perivascular
spaces in the basal ganglia.
Neuropsychological Assessment
Cognitive performance was measured with a comprehensive
neuropsychological assessment at baseline and after 4 years of
follow-up, as has been described before (Uiterwijk et al., 2014).
The test protocol was identical in both patient groups. Memory
domain was measured with the Rey Auditory Verbal Learning
Test (Brand and Jolles, 1985) (immediate recall, delayed recall
and delayed recognition) and the Digit Span Forward [subtest of
Wechsler Adult Intelligence Scale (WAIS)-III (Wechsler, 2001)].
Executive function domain was measured with the Stroop Color
Word Test (Golden, 1978) (SCWT) interference score (time of
part 3minus mean time of parts 1 and 2), Trail Making Test
(TMT) (Reitan, 1956) interference score (time of part B minus
time of part A), Category (animals and professions) (Luteyn,
1966) and Letter Fluency (Lezak et al., 2004), Letter-Number
Sequencing (subtest of WAIS-III), and Digit Span Backward
(subtest of WAIS-III). Information processing speed domain
was measured with the Symbol Substitution - Coding (subtest
of WAIS-III), TMT part A, and SCWT parts 1 and 2. Parallel
versions were used for baseline and follow up assessment for the
Rey Auditory Verbal Learning Test and the Letter Fluency test.
For each patient, we subtracted the raw test scores at follow-
up from test scores at baseline. These raw test decline scores were
transformed into standardized values (z-scores), by dividing the
difference between the individual raw score and the overall group
sample mean by the overall group sample standard deviation
(SD). Z-scores of all tests within one domain were averaged
to receive cognitive decline compound scores of each domain.
In addition, an overall cognitive decline compound score was
calculated by averaging the three domain compound scores.
Higher compound scores indicated higher decline. Z-scores of
tests with higher scores representing worse performance (e.g.,
SCWT and TMT) were inverted before computing the compound
scores.
The Rotterdam - Cambridge Cognitive Examination (R-
CAMCOG) was used to determine the presence of possible
dementia, defined as a score < 34 (de Koning et al., 2005).
Symptoms of depression and anxiety were measured using the
Hospital Anxiety and Depression Scale (HADS) and the total
score (range 0–42) was used. Because symptoms possibly caused
by physical problems (e.g., insomnia or weight loss) are not
included in the HADS, the scale is considered to be suitable to
use in somatic populations (Spinhoven et al., 1997).
Statistical Analysis
Differences in baseline characteristics between uncomplicated
hypertensive patients and hypertensive lacunar stroke patients
were investigated using independent t-test, chi-square test or
Mann–Whitney U test. The associations between SVD score and
age, sex, HADS total score, low or high educational level, and
vascular risk factors were examined using spearman’s correlation
analysis or Mann–Whitney U test. Associations between the
SVD score and cognitive decline (overall cognition and separate
domains of executive functioning, information processing speed
and memory) were investigated using simple linear regression
analyses. Next, the association between SVD score and cognitive
decline was adjusted for possible confounders in three models
of multivariable linear regression analyses. In model 1, the
associations between SVD score and cognitive decline scores were
adjusted for age, sex, educational level, HADS total score, and
potential confounding vascular risk factors (BMI, smoking, and
the presence of diabetes mellitus or hypercholesterolemia). To
avoid overfitting, we only included those vascular risk factors that
were associated with cognitive decline with p < 0.10 in a simple
regression model. In model 2, we corrected for the occurrence
of a symptomatic stroke, by adding patient group (patient
with uncomplicated hypertension or hypertensive lacunar stroke
patient) to the previous model. In model 3, baseline cognitive
performance (of the corresponding cognitive domain) was added
to model 2.
Coefficients of determinations (R2) were calculated in simple
linear regression analyses to determine the proportion of variance
in cognitive decline explained by the SVD score. To investigate
the contribution of each of the markers separately, we repeated
the analyses with WMH, lacunes, microbleeds and perivascular
spaces as predictor individually (dichotomised, as they were
defined in the SVD score) and R2’s were calculated. In addition,
R2 of the full WMH Fazekas score (deep and periventricular
scores summed, score ranging 0–6) was calculated.
IBM SPSS Statistics 22 software was used for all analyses.
Results were considered significant at p< 0.05.
RESULTS
Participants
Flow of participants is shown in Figure 1. We included 112
HYBRiD hypertensive patients and 62 hypertensive lacunar
stroke patients in the present study at baseline. Of these, 91
hypertensive patients and 39 lacunar stroke patients completed
4-year follow-up, giving 130 patients in this study. The mean
follow-up period was 4.04 year (SD = 0.10). Included patients
(n = 130) did not differ from the excluded patients (n = 165)
in age (58.7 ± 12.2 vs. 59.3 ± 13.5 years, respectively, p = 0.70)
or sex (male 57.7% vs. 47.0%, respectively, p = 0.09). Patients
who completed follow-up (n = 130) did not differ from patients
who only completed baseline (n = 44) regarding sex (male
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FIGURE 1 | Participant flow diagram.
TABLE 1 | Patients’ characteristics for uncomplicated hypertensive patients and hypertensive lacunar stroke patients.
Baseline characteristic All patients
(n = 130)
Uncomplicated hypertensive
patients (n = 91)
Hypertensive lacunar stroke
patients (n = 39)
Age, mean (SD), years 58.7 (12.2) 56.3 (11.9) 64.2 (11.1)
Male sex, No. (%) 75 (57.7%) 52 (57.1%) 23 (59.0%)
Educational level, No. (%):
– Low 42 (32.3%) 23 (25.3%) 19 (48.7%)
– Average 42 (32.3%) 33 (36.3%) 9 (23.1%)
– High 46 (35.4%) 35 (38.5%) 11 (28.2%)
HADS total score, median (IQR) 8 (4–13) 7 (4–12) 9 (4–14)
Diabetes Mellitus, No. (%) 3 (2.3%) 1 (1.1%) 2 (5.1%)
Hypercholesterolemia, No. (%)∗ 57 (44.9%) 31 (34.8%) 26 (68.4%)
Current smoking, No. (%) 27 (20.8%) 14 (15.4%) 13 (33.3%)
BMI, mean (SD), kg/m2 27.3 (4.2) 27.4 (4.2) 27.0 (4.0)
SVD score 0, No. (%) 63 (48.5%) 50 (54.9%) 13 (33.3%)
SVD score 1, No. (%) 33 (25.4%) 27 (29.7%) 6 (15.4%)
SVD score 2, No. (%) 18 (13.8%) 8 (8.8%) 10 (25.6%)
SVD score 3, No. (%) 13 (10.0%) 6 (6.6%) 7 (17.9%)
SVD score 4, No. (%) 3 (2.3%) 0 (0.0%) 3 (7.7%)
SD = Standard deviation, HADS = Hospital Anxiety and Depression Scale, IQR = Interquartile range, BMI = Body Mass Index, SVD = Small vessel disease. ∗ Information
about hypercholesterolemia was missing for 3 patients (2 uncomplicated hypertensive patients and 1 hypertensive lacunar stroke patient).
57.7% vs. 59.1%, respectively, p = 0.87), but were younger
(58.7 ± 12.1 vs. 65.1 ± 13.9, respectively, p = 0.004) and had
lower baseline overall cognition compound scores (p = 0.012).
Baseline characteristics, including educational level, HADS score
and vascular risk factors, for the overall group and separately for
uncomplicated hypertensive patients and lacunar stroke patients
are shown in Table 1. Hypertensive lacunar stroke patients
were older (p = 0.001), more often had hypercholesterolemia
(p< 0.001), more often smoked (p= 0.02), had lower educational
levels (p = 0.03), and had higher SVD scores compared
to uncomplicated hypertensive patients (p < 0.001). Other
baseline characteristics did not differ between uncomplicated
hypertensive patients and lacunar stroke patients. Hypertensive
lacunar stroke patients had a lower overall cognition score
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at baseline compared to uncomplicated hypertensive patients
(p < 0.001), but there were no differences in cognitive decline
between patient groups (p = 0.707). Three lacunar stroke
patients had a recurrent stroke during follow-up, while none
of the uncomplicated hypertensive patients had a stroke during
follow-up.
For two patients, one baseline neuropsychological test score
in the domain of executive function was missing. Therefore, for
these patients the executive function decline score was composed
of the remaining 5 tests in this domain. For three patients, the
baseline Rey Auditory Verbal Learning Test was missing. Since
this test determines 3 out of 4 test scores of the memory domain,
no reliable memory decline score could be formed for these two
patients and consequently the overall cognition decline score
was also missing. As a result, analyses of executive function and
information processing speed decline are based on the data of 130
patients, while analyses of overall cognition and memory decline
are based on the data of 127 patients.
SVD Score
Presence of each category of the SVD score is shown in Table 1.
The SVD score correlated with age (p < 0.001) and lower BMI
(p = 0.043), but there were no significant differences in sex,
educational level, HADS total score, or vascular risk factors.
SVD Score and Cognitive Decline
At baseline three patients (2%; 1 uncomplicated hypertensive
patient and 2 lacunar stroke patients) had an R-CAMCOG score
<34, indicating possible dementia. At follow-up, besides these
three patients, six (5%) other patients had a score <34. Three of
these patients were uncomplicated hypertensive patients and six
were hypertensive patients with a lacunar stroke (p= 0.021).
Unadjusted analyses showed an association between SVD
score and cognitive decline in overall cognition, executive
functioning and information processing speed, but not with
memory (Table 2). The association between SVD score
and decline in executive function remained significant after
adjustment for age, sex, educational level, HADS score, and
potential vascular risk factors (Table 2, model 1). Additional
adjustment for patient group with or without additional
adjustment for baseline cognition (of the corresponding cognitive
domain) showed significant associations between SVD score and
decline in overall cognition and executive function (Table 2,
models 2 and 3).
Correlations of determination (R2’s), indicating the
proportions of variance in cognitive decline explained by
SVD score or each of the individual MRI markers are shown in
Table 3. The magnitude of the contributions of the individual
markers (as defined in the SVD score) differed across domains, as
could be seen from the R2’s of the individual markers in Table 3.
The dichotomized WMH explained a smaller proportion of
variance in all cognitive domains, except memory, than the SVD
score. The proportions of variance in the three cognitive domains
explained by the WMH total Fazekas score were comparable to
those explained by the SVD score; in overall cognitive decline
the WMH total Fazekas score explained a higher proportion of
variance than the SVD score.
DISCUSSION
We showed that a total SVD score, that captures total SVD-
related brain damage on MRI imaging, was associated with
cognitive decline in executive function over 4 years in patients
with hypertension.
Previous studies showed associations between cognitive
decline and baseline degree of WMH (Prins et al., 2005;
Jokinen et al., 2011) or number of lacunes (Prins et al., 2005;
Imamine et al., 2011). However, these studies have investigated
associations with individual markers of cerebral SVD and no
other longitudinal study on cognitive decline considered the
total extent of SVD. By capturing all different MRI markers of
cerebral SVD in one measure, we think that the SVD score better
represents the underlying severity of the disease than just one
MRI marker.
Some of the MRI markers of cerebral SVD might be
considered more important than others in the association
with cognitive function. Our results showed that while the
dichotomized WMH explained smaller proportions of variance
in cognitive decline compared to the SVD score, the WMH total
Fazekas score explained similar or even higher proportions of
variance in cognitive decline. This might be explained by a wider
range of severity that is captured by the Fazekas scale (score
ranging 0–6) compared to the SVD score (ranging 0–4). We
believe that the SVD score is an alternative to WMH Fazekas
scale and provides a more complete overview of all SVD-related
brain damage. We advocate that all of these four markers should
be considered together when studying the consequences of SVD-
related brain damage.
Besides the four MRI markers of cerebral SVD included in
the SVD score, other markers of brain damage might influence
cognitive decline, such as cerebral atrophy (Lawrence et al.,
2013) or hippocampal volume (O’Brien et al., 2004). Whether
cerebral atrophy is part of SVD is still a point of discussion.
Cerebral atrophy is not specific for SVD, since it also occurs
in normal aging or can be related to focal injury. Atrophy was
found to be only marginally associated with SVD score (Staals
et al., 2014). However, the unavailability of an atrophy measure
in our data should be considered a limitation of our study. In
addition, all MRI markers in the SVD score are dichotomized,
so degrees of WMH and perivascular spaces or number of
lacunes or microbleeds were not accounted for in the score.
Future research might test different points in the SVD score
for different degrees and thereby may lead to a more optimal
SVD score in predicting cognitive decline. Finally, the SVD score
includes perivascular spaces in the basal ganglia, but not in the
white matter. This can, however, be justified because PVS in
the basal ganglia, not those in the white matter, are associated
with SVD in terms of lacunar stroke (Doubal et al., 2010; Potter
et al., 2015), WMH (Doubal et al., 2010), progression of WMH
(Loos et al., 2015), blood pressure (Klarenbeek et al., 2013a),
and cognition (Huijts et al., 2014). PVS in the white matter
seem to be related to amyloid angiopathy (Charidimou et al.,
2015).
The SVD score has been studied in association with cognitive
performance before, but these studies were cross-sectional. We
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TABLE 2 | Association between small vessel disease (SVD) score and cognitive decline.
Decline in overall
cognition; B
(95%CI)
p Decline in
executive function;
B (95%CI)
p Decline in information
processing speed; B
(95%CI)
p Decline in memory;
B (95%CI)
p
Simple regression
analysis
0.08 (0.02–0.15) 0.017 0.17 (0.09–0.24) <0.001 0.11 (0.007–0.22) 0.037 –0.006 (−0.11–0.10) 0.911
Multivariable regression
analysis model 1
0.07 (−0.01–0.14) 0.072 0.13∗ (0.05–0.21) 0.003 0.08 (−0.04–0.20) 0.179 0.001 (−0.11–0.12) 0.984
Multivariable regression
analysis model 2
0.08 (0.006–0.16) 0.036 0.13∗ (0.04–0.21) 0.005 0.10 (−0.03–0.22) 0.118 0.04 (−0.08–0.15) 0.548
Multivariable regression
analysis model 3
0.09 (0.02–0.16) 0.012 0.13∗ (0.05–0.22) 0.003 0.11 (−0.004–0.23) 0.059 0.05 (−0.04–0.15) 0.271
B = Unstandardized regression coefficient, CI = Confidence interval. Model 1: correction for age, sex, educational level, HADS score, and potential vascular risk factors
(those that were associated with cognitive decline with p < 0.10 in a simple regression model)∗. Model 2: correction for age, sex, educational level, HADS score, potential
vascular risk factors, and patient group. Model 3: correction for age, sex, educational level, HADS score, potential vascular risk factors, patient group, and baseline
cognition. ∗Model includes baseline BMI.
TABLE 3 | R2 for the association between cognitive decline and small vessel disease (SVD) score versus individual MRI markers.
Overall cognition; R2 (p) Executive function; R2 (p) Information processing speed; R2 (p) Memory; R2 (p)
SVD score 4.5% (0.017) 13.0% (<0.001) 3.4% (0.037) 0.0% (0.911)
WMH total Fazekas score 7.8% (0.001) 12.9% (<0.001) 4.3% (0.017) 1.0% (0.259)
WMH (dichotomized)∗ 1.7% (0.139) 6.5% (0.003) 1.6% (0.150) 0.0% (0.938)
Presence of lacunes∗ 2.1% (0.100) 9.6% (<0.001) 0.0% (0.879) 0.2% (0.590)
Presence of microbleeds∗ 1.4% (0.180) 1.2% (0.222) 3.9% (0.024) 0.0% (0.816)
Moderate-severe perivascular spaces∗ 2.5% (0.077) 7.6% (0.002) 3.7% (0.028) 0.4% (0.489)
R2 = Coefficient of determination, SVD = Small vessel disease, WMH =White matter hyperintensities. ∗Presence of individual markers were defined as in the SVD score.
published before (Huijts et al., 2013) on a cohort of 189
lacunar stroke and hypertension patients, of which our present
study cohort is a subset consisting of those patients who
had hypertension and follow-up measurements. In our cross-
sectional baseline study, SVD score was related to information
processing speed and overall cognition, after correction for age
and sex. Another cross-sectional study (Staals et al., 2015) in
an age-cohort of 680 older participants showed that the SVD
score is associated with general cognitive ability. Additional
latent variable modeling analyses was also performed in that
study, which showed that the 4 MRI markers are indeed jointly
indicative of an underlying overall SVD state.
The finding that only decline in executive function is
associated with the SVD score might indicate an expression
of subcortical damage caused by SVD. The result is in line
with a recent study (Lawrence et al., 2015) in patients with
lacunar stroke and leukoaraiosis, in which patients showed a
significant decline in executive function, but not in other domains
(processing speed, working memory, and global cognition).
A major strength is the longitudinal design of our study with
a 4-year follow-up period. In addition, all patients received a
comprehensive neuropsychological assessment, which included
multiple tests in three cognitive domains. A limitation of the
study is the use of variable MRI field strength. Therefore, we
performed sub-analyses including only the patients who were
scanned at 1.5T (n = 109). This showed not only significant
associations between the SVD score and cognitive decline
in overall cognition and executive functioning, but also with
information processing speed, when we used the same variables
as in multivariable regression model 3 (results not shown).
The second limitation is the mixed hypertensive population.
To reach a relatively large sample with a broad spectrum
of severity of cerebral SVD, we included both hypertensive
patients with and without a small vessel stroke. Stroke itself
might have influenced cognition. However, the inclusion of
patient group as a confounder in the model did not change
the results. In addition, three lacunar stroke patients had a
recurrent stroke during follow-up, which might have influenced
cognitive decline. However, results did not change when we
excluded these three patients from analyses (results not shown).
Still, we studied a relatively healthy population; a large part
of the patient group had a SVD score of 0. This might
reduce the generalizability of the results to more affected
patient populations. In addition, results may differ in other
SVD populations, such as in SVD patients with intracerebral
hemorrhage. Lastly, due to selection bias cognitively healthier
people might be included in the study at baseline, which might
have led to an underestimation of the reported associations.
Future studies are needed to investigate the association between
the SVD score and cognitive decline in a more affected and more
homogeneous population.
This longitudinal study investigated a combined score of SVD
MRI markers in relation to cognitive decline and shows that this
score predicts future cognitive decline in executive functioning.
The SVD score might be a good alternative to the Fazekas
WMH score in predicting cognitive decline, since the SVD
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score might provide a more complete overview of total SVD-
related brain damage.
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